NAGE vs ROP · P/E 59, rev $61.3M vs P/E 41, rev $4.20B
Niagen Bioscience, Inc. (NAGE) versus Roper Technologies, Inc. (ROP) — a side-by-side from cached financials, not a winner call.
Niagen Bioscience, Inc. (NAGE) is a biotechnology company listed on US.
Roper Technologies, Inc. (ROP) is a software - application company listed on US.
Latest reported NAGE revenue for 2026-06-30 was $61.3M. Net income was $7.3M. Revenue was up 94.6% from 2026-03-31 to 2026-06-30. NAGE currently screens at market cap $836.5M and trailing P/E 59.0.
Latest reported ROP revenue for 2026-06-30 was $4.20B. Net income was $1.68B. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
NAGE currently screens at market cap $836.5M and trailing P/E 59.0. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
Not investment advice. Open the NAGE and ROP stock pages for the full models.
Not investment advice.